The Dermatology Digest

MARCH 26, 2024

“While NCE status will provide YCANTH with a minimum of five years of protection, we anticipate our full patent portfolio to provide protection from generic competition for the next decade and potentially beyond,” says Ted White, Verrica’s President and Chief Executive Officer, in a news release.

Pharmaceutical 36

Pharmaceutical Portfolios Office Marketing 36

The Dermatology Digest

FEBRUARY 28, 2024

The new Consumer Skincare Division, led by Steve Gallopo, Executive Vice President and Chief Commercial Officer, will combine resources of the previously separate units. Crown Laboratories, Inc. is consolidating its Premium Skincare and Therapeutic business units into a single Consumer Skincare Division.

Skincare 36

Skincare Portfolios Innovations Office 36

The Dermatology Digest

APRIL 1, 2024

“We are excited to announce the addition of this collaboration for povorcitinib, expanding our relationship with CMS in the Dermatology space beyond ruxolitinib cream, to include two products with the potential to help patients with limited treatment options,” says Hervé Hoppenot, Chief Executive Officer, Incyte, in a news release.

Portfolios 36

Portfolios Injections Innovations Sales 36

The Dermatology Digest

OCTOBER 1, 2024

“We are encouraged by the outcome from the recent FDA meeting and the opportunity to advance our development of prabotulinumtoxinA utilizing the 351(k) biosimilar regulatory pathway,” says Marc Forth, AEON’s President and Chief Executive Officer, in a news release. “We

Hydration 36

Hydration Portfolios Office Surgery 36

The Dermatology Digest

JANUARY 2, 2024

Dennis Gross Skincare is the perfect complement to our global portfolio of prestige brands as their core values are aligned with ours in terms of their scientific and innovative approach to beauty and our people-first culture.”

Dermatology 36

Dermatology Sales Skincare Portfolios 36

Spa Executive

OCTOBER 23, 2024

Travelers don’t just want to choose their own adventure – they want to maximize every moment of their time away,” said Chris Nassetta, president and chief executive officer, Hilton. These findings highlight new opportunities for us to innovate across our global portfolio and further enhance guests’ stays.

Portfolios 52

Portfolios Technology Social Media Branding 52

Southeastern Esthetics Institute

AUGUST 23, 2016

Specific courses for cosmetic lasers, for example, are crucial to add to the esthetics portfolio, in order to showcase added training beyond that of the esthetics fundamentals course. A complete system must be in place per office, for the role of every action within the practice.

Esthetician 195

Esthetician Esthetics Document Office 195

Spa Executive

AUGUST 27, 2024

Roger Sholanki, Book4Time Founder and Chief Executive Officer, commented, “Over the past 20 years, we have worked hand-in-hand with the world’s leading hospitality brands in over 100 countries to develop the industry’s #1 SaaS platform for spa and wellness operations.

Management 52

Management Hospital Technology Sales 52

AAAMS

FEBRUARY 22, 2023

Office politics are reduced as complex hierarchies are no longer present. You’ll Experience Enhanced Job Security In the world of finance, a diversified investment portfolio is the key to mitigating risk and creating greater financial stability. Practitioners are free and encouraged to exercise their best medical judgment.

Work-Life Balance 52

Work-Life Balance Training Office Marketing 52

The Dermatology Digest

DECEMBER 21, 2023

and Europe will complement the recent launch of Nuceiva, our flagship neurotoxin, which has been met with very strong interest and growing demand from customers,” says David Moatazedi, President and Chief Executive Officer of Evolus, in a news release. “We “The addition of the Estyme facial fillers in the U.K.

Marketing 36

Marketing Sales Branding Portfolios 36

The Dermatology Digest

DECEMBER 21, 2023

and Europe will complement the recent launch of Nuceiva, our flagship neurotoxin, which has been met with very strong interest and growing demand from customers,” says David Moatazedi, President and Chief Executive Officer of Evolus, in a news release. “We “The addition of the Estyme facial fillers in the U.K.

Marketing 36

Marketing Sales Branding Portfolios 36

The Dermatology Digest

MARCH 5, 2024

Chief Executive Officer of Apogee, in a news release.

Injections 36

Injections Safety Sustainability Clinic 36

Aesthetics Advisor

SEPTEMBER 15, 2023

It’s pure commonsense ,” Nathan Jones, chief executive officer of Xlear said in a statement. We are very confident in these results that show Carragelose inactivates SARS-CoV-2, independent of the mutations we tested ,” said Dr. Eva Prieschl-Grassauer, Chief Scientific Officer at Marinomed.

Hospital 69

Hospital Clinic Marketing Medical 69